What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 4, Issue 3, 2001, Pages 183-190

  Jagoe, R Thomas ^a   Goldberg, Alfred L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; MESSENGER RNA; MULTIENZYME COMPLEX; MUSCLE PROTEIN; PROTEASOME; UBIQUITIN;

ANIMAL; CULTURE TECHNIQUE; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MUSCLE ATROPHY; NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER; REVIEW; SKELETAL MUSCLE; WASTING SYNDROME;

NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER;

ANIMALS; CULTURE TECHNIQUES; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; HUMANS; MULTIENZYME COMPLEXES; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; UBIQUITINS; WASTING SYNDROME;

EID: 0035350530     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200105000-00003     Document Type: Article

References (58)

1. Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994; 78:761-771.
2. Schwartz AL, Ciechanover A. The ubiquitin - proteasome pathway and pathogenesis of human diseases. Annu Rev Med 1999; 50:57-74. Clearly written with a discussion on the link between the ubiquitin - proteasome pathway and particular human diseases.
3. Baumeister W, Walz J, Zuhl F, et al. The proteasome: paradigm of a self-compartmentalizing protease. Cell 1998; 92:367-380.
4. Pickart CM. Ubiquitin in chains. Trends Biochem Sci 2000; 25:544-548.
5. Lam YA, Xu W, DeMartino GN, et al. Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome. Nature 1997; 385:737-740.
6. Deshaies RJ. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu Rev Cell Dev Biol 1999; 15:435-467.
7. Solomon V, Lecker SH, Goldberg AL. The N-end rule pathway catalyzes a major fraction of the protein degradation in skeletal muscle. J Biol Chem 1998; 273:25216-25222.
8. Bastians H, Topper LM, Gorbsky GL, et al. Cell cycle-regulated proteolysis of mitotic target proteins. Mol Biol Cell 1999; 10:3927-3941.
9. Chen Z, Hagler J, Palombella VJ, et al. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin - proteasome pathway. Genes Dev 1995; 9:1586-1597.
10. Lecker SH, Solomon V, Mitch WE, et al. Muscle protein breakdown and the critical role of the ubiquitin - proteasome pathway in normal and disease states. J Nutr 1999; 129(Suppl):227S-237S. A detailed and current review with informative figures and summary tables.
11. Furuno K, Goldberg AL. The activation of protein degradation in muscle by Ca2+ or muscle injury does not involve a lysosomal mechanism. Biochem J 1986; 237:859-864.
12. Lowell BB, Ruderman NB, Goodman MN. Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem J 1986; 234:237-240.
13. Etlinger JD, Goldberg AL. A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes. Proc Natl Acad Sci USA 1977; 74:54-58.
14. Hershko A, Ciechanover A. The ubiquitin system for protein degradation. Annu Rev Biochem 1992; 61:761-607.
15. Medina R, Wing SS, Haas A, et al. Activation of the ubiquitin - ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy. Biomed Biochim Acta 1991; 50:347-356.
16. Taillandier D, Aurousseau E, Meynial-Denis D, et al. Coordinate activation of lysosomal. Ca 2+-activated and ATP - ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem J 1996; 316:65-72.
17. Mitch WE, Medina R, Grieber S, et al. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 1994; 93:2127-2133.
18. Wing SS, Goldberg AL. Glucocorticoids activate the ATP - ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol 1993; 264:E668-E676.
19. Temparis S, Asensi M, Taillandier D, et al. Increased ATP - ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res 1994; 54:5568-5573.
20. Llovera M, Garcia-Martinez C, Agell N, et al. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int J Cancer 1995; 61:138-141.
21. Baracos VE, DeVivo C, Hoyle DHR, et al. Activation of the ATP - ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol 1995; 268:E996-E1006.
22. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998; 8:397-403.
23. Price SR, Bailey JL, Wang X, et al. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin - proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest 1996; 98:1703-1708.
24. Bailey JL, Wang X, England BK, et al. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin - proteasome pathway. J Clin Invest 1996; 97:1447-1453.
25. Tawa NE, Odessey R, Goldberg AL. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest 1997; 100:197-203.
26. Furuno K, Goodman MN, Goldberg AL. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. J Biol Chem 1990; 265:8550-8557.
27. Tiao G, Fagan J, Roegner V, et al. Energy - ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest 1996; 97:339-348.
28. Medina R, Wing SS, Goldberg AL. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J 1995; 307:631-637.
29. Llovera M, Garcia-Martinez C, Agell N, et al. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett 1994; 338:311-318.
30. Voisin L, Breuille D, Combaret L, et al. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+-activated, and ubiquitin - proteasome proteolytic pathways. J Clin Invest 1996; 97:1610-1617.
31. Auclair D, Garrel DR, Chaouki Zerouala A, et al. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. Am J Physiol 1997; 272:C1007-C1016.
32. Mitch WE, Bailey JL, Wang X, et al. Evaluation of signals activating ubiquitin -proteasome proteolysis in a model of muscle wasting. Am J Physiol 1999; 276:C1132-C1138. The first study to attempt to dissect the relative importance of the different extracellular signals which activate the ubiquitin - proteasome pathway in diabetic acidosis.
33. Wing SS, Haas AL, Goldberg AL. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. Biochem J 1995; 307:639-645.
34. Hobler SC, Williams A, Fischer D, et al. Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis. Am J Physiol 1999; 277:R434-R440.
35. Wing SS, Banville D. 14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. Am J Physiol 1994; 267:E39-E48.
36. Lecker SH, Solomon V, Price SR, et al. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J Clin Invest 1999; 104:1411-1420. The first study of ubiquitination rates in extracts from diabetic rats, and the only one to combine detailed analysis of mRNA, protein and activity assays of the components of the 'N-end rule' pathway.
37. Hobler SC, Wang JJ, Williams AB, et al. Sepsis is associated with increased ubiquitin-conjugating enzyme E214k mRNA in skeletal muscle. Am J Physiol 1999; 276:R468-R473.
38. Chrysis D, Underwood LE. Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone. Endocrinology 1999; 140:5635-5641. The first study to show changes in three different E2 in muscle atrophy.
39. Fischer D, Sun X, Gang G, et al. The gene expression of ubiquitin ligase E3alpha is upregulated in skeletal muscle during sepsis in rats - potential role of glucocorticoids. Biochem Biophys Res Commun 2000; 267:504-508.
40. Solomon V, Goldberg AL. Importance of the ATP - ubiquitin - proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 1996; 271:26690-26697.
41. Solomon V, Baracos V, Sarraf P, et al. Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway. Proc Natl Acad Sci USA 1998; 95:12602-12607.
42. Solomon V, Madihally S, Yarmush M, et al. Insulin suppresses the increased activities of lysosomal cathepsins and ubiquitin conjugation system in burn-injured rats. J Surg Res 2000; 93:120-126.
43. Bachmair A, Finley D, Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Science 1986; 234:179-186.
44. Varshavsky A. The N-end rule: functions, mysteries, uses. Proc Natl Acad Sci USA 1996; 93:12142-12149.
45. 2-terminal residue of proteins to ubiquitin-protein ligase. Use of amino acid derivatives to characterize specific binding sites. J Biol Chem 1988; 263:2693-2698.
46. Baker RT, Varshavsky A. Inhibition of the N-end rule pathway in living cells. Proc Natl Acad Sci USA 1991; 88:1090-1094.
47. Turner GC, Du F, Varshavsky A. Peptides accelerate their uptake by activating a ubiquitin-dependent proteolytic pathway. Nature 2000; 405:579-583.
48. Bartel B, Wunning I, Varshavsky A. The recognition component of the N-end rule pathway. EMBO J 1990; 9:3179-3189.
49. Kayalar C, Ord T, Testa MP, et al. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci USA 1996; 93:2234-2238.
50. Williams AB, Decourten-Myers GM, Fischer JE, et al. Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. FASEB J 1999; 13:1435-1443.
51. Grigoryev S, Stewart AE, Kwon YT, et al. A mouse amidase specific for N-terminal asparagine. The gene, the enzyme, and their function in the N-end rule pathway. J Biol Chem 1996; 271:28521-28532.
52. 2 termini substrates of the ubiquitin pathway. J Biol Chem 1988; 263:11155-11167.
53. Gonen H, Stancovski I, Shkedy D, et al. Isolation, characterization, and partial purification of a novel ubiquitin-protein ligase, E3. Targeting of protein substrates via multiple and distinct recognition signals and conjugating enzymes. J Biol Chem 1996; 271:302-310.
54. Roest HP, van Klaveren J, de Wit J, et al. Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification. Cell 1996; 86:799-810.
55. Kwon YT, Reiss Y, Fried VA, et al. The mouse and human genes encoding the recognition component of the N-end rule pathway. Proc Natl Acad Sci USA 1998; 95:7898-7903.
56. Williams A, Sun X, Fischer JE, et al. The expression of genes in the ubiquitin -proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery 1999; 126:744-749. The first study to show increases in mRNA for ubiquitin and 20S proteasome subunits in muscle biopsies from humans with cancer.
57. Tiao G, Hobler S, Wang JJ, et al. Sepsis is associated with increased mRNAs of the ubiquitin - proteasome proteolytic pathway in human skeletal muscle. J Clin Invest 1997; 99:163-168.
58. Mansoor O, Beaufrere B, Boirie Y, et al. Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP - ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc Natl Acad Sci USA 1996; 93:2714-2718.